Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qilin Feng

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 16, 2025
Pre-Constructed Mechano-Electrochemical Adaptive Solid Electrolyte Interphase to Enhance Li<sup>+</sup> Diffusion Kinetics and Interface Stability for Chemically Prelithiated SiO AnodesZhan Wang, Shuang Li, Yun Zheng, et al.
Animals : an Open Access Journal From MDPI|December 11, 2025
Intestinal Development Patterns and Gut Microbiota Colonization Dynamics in Sichuan Bream (<i>Sinibrama taeniatus</i>)Shixia Huang, Qiang Zhao, Chao Deng, et al.
American Journal of Translational Research|November 17, 2021
A novel silicone derivative of natural osalmid (DCZ0858) exerts anti-multiple myeloma activity by promoting cell apoptosis and inhibiting cell cycle and mTOR signalingWenxuan Bu, Bo Li, Lijin Feng, et al.
Life Sciences|January 12, 2020
Antitumor effects of rafoxanide in diffuse large B cell lymphoma via the PTEN/PI3K/Akt and JNK/c-Jun pathwaysWan He, Zhijian Xu, Dongliang Song, et al.
Cancer Cell International|May 31, 2021
A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-κB pathwayXuejie Gao, Bo Li, Anqi Ye, et al.
Journal of Cancer|July 7, 2020
Glycolysis is suppressed by DCZ0801-induced inactivation of the Akt/mTOR pathway in Multiple MyelomaQilin Feng, Qingchun Yao, Bo Li, et al.
International Immunopharmacology|December 29, 2023
A novel pterostilbene compound DCZ0825 induces macrophage M1 differentiation and Th1 polarization to exert anti-myeloma and immunomodulatoryHui Zhang, Ke Hu, Yumeng Lu, et al.
Archives of Biochemistry and Biophysics|September 30, 2023
Molecular mechanism by which RRM2-inhibitor (cholagogue osalmid) plus bafilomycin A1 cause autophagic cell death in multiple myelomaShushan Guo, Zhijian Xu, Qilin Feng, et al.
Translational Oncology|November 15, 2025
Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in multiple myelomaLi Xu, Hui Zhang, Kai Wang, et al.
International Immunopharmacology|November 1, 2023
Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cellsQilin Feng, Ke Hu, Huifang Hu, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 16, 2025
Pre-Constructed Mechano-Electrochemical Adaptive Solid Electrolyte Interphase to Enhance Li<sup>+</sup> Diffusion Kinetics and Interface Stability for Chemically Prelithiated SiO AnodesZhan Wang, Shuang Li, Yun Zheng, et al.
Animals : an Open Access Journal From MDPI|December 11, 2025
Intestinal Development Patterns and Gut Microbiota Colonization Dynamics in Sichuan Bream (<i>Sinibrama taeniatus</i>)Shixia Huang, Qiang Zhao, Chao Deng, et al.
American Journal of Translational Research|November 17, 2021
A novel silicone derivative of natural osalmid (DCZ0858) exerts anti-multiple myeloma activity by promoting cell apoptosis and inhibiting cell cycle and mTOR signalingWenxuan Bu, Bo Li, Lijin Feng, et al.
Life Sciences|January 12, 2020
Antitumor effects of rafoxanide in diffuse large B cell lymphoma via the PTEN/PI3K/Akt and JNK/c-Jun pathwaysWan He, Zhijian Xu, Dongliang Song, et al.
Cancer Cell International|May 31, 2021
A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-κB pathwayXuejie Gao, Bo Li, Anqi Ye, et al.
Journal of Cancer|July 7, 2020
Glycolysis is suppressed by DCZ0801-induced inactivation of the Akt/mTOR pathway in Multiple MyelomaQilin Feng, Qingchun Yao, Bo Li, et al.
International Immunopharmacology|December 29, 2023
A novel pterostilbene compound DCZ0825 induces macrophage M1 differentiation and Th1 polarization to exert anti-myeloma and immunomodulatoryHui Zhang, Ke Hu, Yumeng Lu, et al.
Archives of Biochemistry and Biophysics|September 30, 2023
Molecular mechanism by which RRM2-inhibitor (cholagogue osalmid) plus bafilomycin A1 cause autophagic cell death in multiple myelomaShushan Guo, Zhijian Xu, Qilin Feng, et al.
Translational Oncology|November 15, 2025
Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in multiple myelomaLi Xu, Hui Zhang, Kai Wang, et al.
International Immunopharmacology|November 1, 2023
Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cellsQilin Feng, Ke Hu, Huifang Hu, et al.
Pageof 5